XML 66 R46.htm IDEA: XBRL DOCUMENT
v3.19.3

Collaboration Agreements - Aurigene Discovery Technologies Limited (Aurigene) Collaboration (Details) $ in Millions | 1 Months Ended |
--- | --- | ---
Jul. 31, 2019 USD ($) program | Sep. 27, 2019 USD ($)
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] |  |
Additional option payments | $ 7.5 |
Collaboration Agreement With Aurigene Discovery Technologies Limited Collaboration Agreement |  |
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] |  |
Collaboration agreement, number of programs | program | 6 |
Upfront payment | $ 10.0 |
Collaboration agreement, number of preexisting programs | program | 3 |
Collaboration agreement, number of drug discovery programs | program | 3 |
Research and development obligation | $ 32.6 |
Preclinical development funding commitment accrued |  | $ 1.3
Maximum amount eligible for development and regulatory milestones | 148.8 |
Maximum amount eligible for commercial milestones under collaborations agreement | 280.0 |
Collaboration Agreement With Aurigene Discovery Technologies Limited Collaboration Agreement | Minimum |  |
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] |  |
Option exercise fee payment, if exercised | 10.0 |
Collaboration Agreement With Aurigene Discovery Technologies Limited Collaboration Agreement | Maximum |  |
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] |  |
Option exercise fee payment, if exercised | $ 12.0 |

X
- Definition Collaboration Agreement, Additional Option Payments + References No definition available. + Details
Name: | exel_CollaborationAgreementAdditionalOptionPayments
Namespace Prefix: | exel_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Collaboration Agreement, Number Of Drug Discovery Programs + References No definition available. + Details
Name: | exel_CollaborationAgreementNumberOfDrugDiscoveryPrograms
Namespace Prefix: | exel_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | instant

X
- Definition Collaboration Agreement, Number Of Preexisting Programs + References No definition available. + Details
Name: | exel_CollaborationAgreementNumberOfPreexistingPrograms
Namespace Prefix: | exel_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | instant

X
- Definition Collaboration Agreement, Number Of Programs + References No definition available. + Details
Name: | exel_CollaborationAgreementNumberOfPrograms
Namespace Prefix: | exel_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | instant

X
- Definition Collaboration Agreement, Option Exercise Fee Payment, Upon Exercising Option + References No definition available. + Details
Name: | exel_CollaborationAgreementOptionExerciseFeePaymentUponExercisingOption
Namespace Prefix: | exel_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Collaboration Agreement, Research And Development Expense Accrued + References No definition available. + Details
Name: | exel_CollaborationAgreementResearchAndDevelopmentExpenseAccrued
Namespace Prefix: | exel_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Collaboration Agreement, Research And Development Obligation + References No definition available. + Details
Name: | exel_CollaborationAgreementResearchAndDevelopmentObligation
Namespace Prefix: | exel_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Collaboration Agreements, Upfront Payments + References No definition available. + Details
Name: | exel_CollaborationAgreementsUpfrontPayments
Namespace Prefix: | exel_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Collaborative Agreement, Maximum Amount Eligible For Commercial Milestones Under Collaborations Agreement + References No definition available. + Details
Name: | exel_CollaborativeAgreementMaximumAmountEligibleForCommercialMilestonesUnderCollaborationsAgreement
Namespace Prefix: | exel_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Maximum amount eligible for development and regulatory milestones under collaborations agreement. + References No definition available. + Details
Name: | exel_CollaborativeArrangementMaximumAmountEligibleForDevelopmentAndRegulatoryMilestones
Namespace Prefix: | exel_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=exel_CollaborationAgreementWithAurigeneDiscoveryTechnologiesLimitedCollaborationAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MinimumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |